UiPath raises $225m in Series E funding and secures valuation of $10.2bn
International Robotic Process Automation (RPA) company, UiPath, today announced it has closed its Series E investment round, raising $225m at a post-money valuation of $10.2bn.
The round was led by Alkeon Capital Management. Others participating include Accel, Coatue, Dragoneer, IVP, Madrona Venture Group, Sequoia Capital, Tencent, Tiger Global, Wellington, and funds and accounts advised by T. Rowe Price Associates, Inc. At over $400m in ARR, UiPath is one of the fastest-growing enterprise software companies worldwide.
According to Forrester Research: “As we emerge from the crisis, firms will look to automation as a way to mitigate the risks that future crises pose to the supply and productivity of human workers.”
With automation now becoming a boardroom imperative with new urgency, UiPath will use this funding to deepen its investment in research and development. Having announced the availability of its end-to-end hyperautomation platform in May 2020, UiPath is focused on accelerating and democratising automation adoption to help customers deliver a better customer experience so employees worldwide can use, and also experience optimal value from, software robots.
Whether on-premise or in the cloud, UiPath customers are afforded flexible deployment options best suited for their organisation.
Daniel Dines, UiPath Co-Founder and CEO said: “This funding allows us to accelerate our platform ambitions to meet mounting customer demands and scale the tremendous opportunity to bring automation to one billion citizen developers – resulting in every business finally becoming a software business.
“We will advance our market-leading platform and will continue to deepen our investments in AI-powered innovation and expanded cloud offerings. COVID-19 has heightened the critical need of automation to address challenges and create value in days and weeks, not months and years. We are committed to working harder to help our customers evolve, transform, and succeed fast in the new normal.”